Cerebral Edema in Lecanemab Treatment for Alzheimer’s Disease: A Comprehensive Review of Mechanisms, Risk Factors, Imaging, and Management
Abstract Lecanemab, a monoclonal antibody targeting amyloid-beta protofibrils, has emerged as a promising disease-modifying therapy for early Alzheimer’s disease (AD). However, its use is associated with amyloid-related imaging abnormalities (ARIA), particularly ARIA-E (edema), which presents […]
